SCA Pharma
Jeff Prosterman has extensive experience in the pharmaceutical industry, currently serving as an Investigator II at the FDA since December 2024. Prior to this role, Jeff Prosterman held various positions, including Lab Manager at SCA Pharmaceuticals since March 2017 and Vice President of Quality Regulatory and Safety at Ultimate Nutrition from October 2016 to March 2017. Jeff Prosterman also served as the Director of Laboratory and Operations at Curaleaf from May 2014 to September 2016, and as Senior Manager QC at Contract Pharmacal Corp from July 2011 to June 2014. Initial roles included Chemist III at Epic Pharma and Scientist I at Teva Pharmaceuticals, where contributions were made toward several "first to file" submissions. Jeff Prosterman began his career as a Scientist at AAI and a Chemist at Schering Plough after earning a Bachelor's degree in Chemistry from the University of Tennessee at Chattanooga from 1985 to 1990.
This person is not in any teams
This person is not in any offices
SCA Pharma
1 followers
Enhanced Healthcare Partners is focused on partnering with companies exclusively in the healthcare sector, working hand in hand with company leadership to drive intelligent strategy, build great teams, and develop lasting operational infrastructure. Success in healthcare starts with the people, from managers to providers, and Enhanced investmentprocesses build alignment across the organization, fostering a patient-centric, growth-oriented culture. As seasoned experts with over 100 years of combined healthcare experience and exited investments in over 20 subsectors across the healthcare industry, the Enhanced team is focused on helping growing companies achieve their next significant milestone and beyond.